This is a retrospective review of 143 patients requiring reoperation after an initial AVR with a Freestyle® stentless bioprosthesis. Valve survival was 10.4 years for those with structural valve deterioration, but it was much less (4.1 years) if the initial procedure was for infective endocarditis. Operative mortality was
You are here:
Aortic Valve Reoperation Following Stentless Bioprosthesis: Short- and Long-Term Outcomes
Submitted by: Benjamin Bidstrup
Source: The Annals of Thoracic Surgery
Keywords:
Author(s): Bo Yang, Himanshu J. Patel, Elizabeth L. Norton, Christina Debenedictus, Linda Farhat, Xiaoting Wu, Kevin He, Whitney E. Hornsby, Donald S. Likosky, G. Michael Deeb
